文献速递心血管腹部CTPET

CT检出的非酒精性脂肪性肝病与心肌灌注PET/CT显示的冠状动脉微血管功能障碍之间的关联

Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
PubMed 文献 · Radiology · 2019-03-05

本回顾性研究纳入886例无阻塞性心外膜冠状动脉疾病且左心室射血分数≥40%的患者,基于CT平均肝衰减<40 HU定义非酒精性脂肪性肝病(NAFLD),以冠状动脉血流储备(CFR)<2.0定义冠状动脉微血管功能障碍。NAFLD患者冠状动脉微血管功能障碍患病率更高(64.8% vs 43.4%,P < .001)且CFR更低(1.9 ± 1.1 vs 2.2 ± 0.7,P < .001),NAFLD独立预测冠状动脉微血管功能障碍(P = .01),冠状动脉微血管功能障碍与主要不良心脏事件相关(校正风险比1.46,95%CI:1.02, 2.07;P = .04)。

要点

  • CT平均肝衰减<40 HU定义的NAFLD患者冠状动脉微血管功能障碍(CFR<2.0)患病率更高(64.8% vs 43.4%)。
  • NAFLD患者CFR更低(1.9 ± 1.1 vs 2.2 ± 0.7),NAFLD独立预测冠状动脉微血管功能障碍(P = .01)。
  • 冠状动脉微血管功能障碍与主要不良心脏事件相关(校正风险比1.46,95%CI:1.02, 2.07;P = .04)。

核心结论

  • 在无阻塞性心外膜冠状动脉疾病且左心室射血分数≥40%的患者中,冠状动脉微血管功能障碍在NAFLD患者中更常见,且冠状动脉微血管功能障碍独立于NAFLD预测主要不良心脏事件。

研究设计与样本

  • 回顾性研究(2006-2014年),纳入886例无阻塞性心外膜冠状动脉疾病证据且左心室射血分数≥40%、接受临床静息和负荷心肌灌注PET/CT的患者;NAFLD由CT平均肝衰减<40 HU定义,冠状动脉微血管功能障碍由冠状动脉血流储备(CFR)<2.0定义。

关键影像表现/征象

  • NAFLD由CT平均肝衰减<40 HU定义,886例中125例(14.1%)存在NAFLD。
  • 冠状动脉微血管功能障碍由CFR<2.0定义,886例中411例(46.4%)存在冠状动脉微血管功能障碍。
  • NAFLD患者冠状动脉微血管功能障碍患病率为64.8%,无NAFLD患者为43.4%(P < .001)。
  • NAFLD患者CFR为1.9 ± 1.1,无NAFLD患者为2.2 ± 0.7(P < .001)。

诊断标准与关键数值

  • NAFLD诊断标准:CT平均肝衰减<40 HU。
  • 冠状动脉微血管功能障碍诊断标准:冠状动脉血流储备(CFR)<2.0。
  • NAFLD独立预测冠状动脉微血管功能障碍(P = .01)。
  • NAFLD与男性性别交互作用预测主要不良心脏事件(风险比1.45,95%CI:1.08, 1.69;P = .008)。
  • 冠状动脉微血管功能障碍与主要不良心脏事件相关(校正风险比1.46,95%CI:1.02, 2.07;P = .04)。

临床应用与阅片要点

  • 在心肌灌注PET/CT评估中,可同时关注CT所见的肝脏衰减(平均肝衰减<40 HU提示NAFLD)与CFR(<2.0提示冠状动脉微血管功能障碍)。
  • NAFLD患者中冠状动脉微血管功能障碍患病率更高(64.8% vs 43.4%),阅片时可留意两者并存的可能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Cardiovascular disease is a major cause of mortality in patients with nonalcoholic fatty liver disease (NAFLD). However, the association of NAFLD with coronary microvascular dysfunction is, to our knowledge, unknown. Purpose To determine whether coronary microvascular dysfunction is more prevalent in patients with NAFLD and to determine whether coronary microvascular dysfunction predicts major adverse cardiac events (MACE) independently of NAFLD. Materials and Methods This retrospective study (2006-2014) included patients without evidence of obstructive epicardial coronary artery disease and healthy left ventricular ejection fraction (≥40%) at a clinical rest and stress myocardial perfusion PET/CT. NAFLD was defined by a mean hepatic attenuation of less than 40 HU at CT and coronary microvascular dysfunction as a coronary flow reserve (CFR) of less than 2.0. A composite of all-cause mortality, myocardial infarction, coronary revascularization, and hospitalization because of heart failure comprised MACE (130 of 886 patients; 14.7%). The relation between NAFLD and MACE was assessed by using multivariable Cox regression analysis. Results Among 886 patients (mean age, 62 years ± 12 [standard deviation]; 631 women [mean age, 62 years ± 12 years] and 255 men [mean age, 61 years ± 12]; and ejection fraction, 63% ± 9), 125 patients (14.1%) had NAFLD and 411 patients (46.4%) had coronary microvascular dysfunction. Coronary microvascular dysfunction was more prevalent (64.8% vs 43.4%; P < .001) and CFR was lower (1.9 ± 1.1 vs 2.2 ± 0.7; P < .001) in patients with NAFLD compared with those without NAFLD. NAFLD independently predicted coronary microvascular dysfunction (P = .01). The interaction of NAFLD and male sex predicted MACE (hazard ratio, 1.45; 95% confidence interval: 1.08, 1.69; P = .008) and coronary microvascular dysfunction remained associated with MACE (adjusted hazard ratio, 1.46; 95% confidence interval: 1.02, 2.07; P = .04). Conclusion Coronary microvascular dysfunction was more prevalent in patients with nonalcoholic fatty liver disease and predicted major adverse cardiac events independently of nonalcoholic fatty liver disease. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Ambale-Venkatesh and Lima in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Vita T, Murphy DJ, Osborne MT, et al. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019. PMID: 30835188. doi:10.1148/radiol.2019181793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。